Substance active (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Informations techniques
Présentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
1ZaUhaXSBQh2KXMs